NNG Share Price Performance
zł2.58
-0.53 (-17.20%)
Price zł2.58
fis_wse
Share Pricen/a
NanoGroup S.A. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
NNG Community Narratives
FI
Fair Value zł0 n/aintrinsic discount
Expect big change: Nanogroup's NanOX system will tackle global kidney shortages
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
Expect big change: Nanogroup's NanOX system will tackle global kidney shortages
Overview of Nanogroup and the NanOX Project Nanogroup is focused on addressing the critical shortage of organs for transplantation, particularly kidneys, which are essential for treating end-stage renal disease. The organization has developed an innovative solution known as the NanOX system , designed to improve the availability, preservation, and success rates of kidney transplants.Read more
104
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
Trending Discussion
Recently Updated Narratives
FI
Expect big change: Nanogroup's NanOX system will tackle global kidney shortages
Fair Value: zł0 0% overvalued intrinsic discount
10 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
NanoGroup S.A. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.21
- 3,716.80%
- 100,429.90%
- 0%
About NNG
- Founded
- 2016
- Employees
- n/a
- CEO
- WebsiteView website
NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantology. The company was founded in 2016 and is based in Warsaw, Poland.
